IDEA Pharma – Vyvanse Positioning Case Study
IDEA Pharma work with Biopharma from early through late phase development to deliver best-in-class positioning and path-to-market strategy. The IDEA Pharma […]
IDEA Pharma work with Biopharma from early through late phase development to deliver best-in-class positioning and path-to-market strategy. The IDEA Pharma […]
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but
As recently profiled in the New York Times, the rise of AI chatbots in healthcare is fundamentally changing how patients form
Jacqueline Poot President – Strategic Consulting & Analytics BU IDEA Pharma As a moderator of this session at BIOEuropeSpring, my
IDEA Pharma Announces Acceptance of Campfire Session at 39th ECNP Congress 2026 Highlighting Urgent Need to Rethink Development in CIAS
In this episode of IDEA Collider, host Mike Rea sits down with Michelle Werner, CEO of Alltrna, to explore a
Building on the China Pharmaceutical Innovation and Invention Index, which assesses the overall innovation strength of leading Chinese pharmaceutical companies, here
In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the
In this episode of IDEA Collider, host Mike Rea speaks with Dr. Sekar Kathiresan, founder of Verve Therapeutics and now part of Eli Lilly, about
What Works, What Kills What, and Why It Matters By Mike Rea In pharmaceutical R&D, where billions ride on the